Bookmark and Share
BioAssay: AID 1742

Quantitative High-Throughput Screen for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay: Summary

The Ras/extracellular-signal-regulated kinase (ERK) mitogen activated protein (MAP) kinase signaling pathway (ERK1/2 cascade) plays is a key role in transmitting signals from the cell surface to the nucleus (Nishida and Gotoh 1993; Chang and Karin, 2001). The cascade is initiated by the small G-protein Ras, which recruits Raf from the cytosol, where activation occurs. Alternatively, this pathway can be activated by elevating intracellular cAMP. ..more
_
   
 Tested Compounds
 Tested Compounds
All(10)
 
 
Probe(1)
 
 
Active(10)
 
 
 Tested Substances
 Tested Substances
All(10)
 
 
Probe(1)
 
 
Active(10)
 
 
AID: 1742
Data Source: NCGC (ERKS590)
BioAssay Type: Summary, Candidate Probes/Leads with Supporting Evidence
Depositor Category: NIH Molecular Libraries Screening Center Network
BioAssay Version:
Deposit Date: 2009-05-11
Modify Date: 2010-06-28

Data Table ( Complete ):           View Active Data    View All Data
Target
BioActive Compounds: Chemical Probe: 1    Active: 10
Related Experiments
Show more
AIDNameTypeComment
995qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening AssayConfirmatorydepositor-specified cross reference: Vasopressin induced cell-based ERK primary assay
1454qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGFConfirmatorydepositor-specified cross reference: EGF induced cell-based ERK primary assay
1724Confirmation Concentration-Response Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening AssayConfirmatorydepositor-specified cross reference: Vasopressin induced cell-based ERK confirmation assay
1725Confirmation Concentration-Response Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGFConfirmatorydepositor-specified cross reference: EGF induced cell-based ERK primary confirmation assay
1726Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay: EGFR T790M/L858R Kinase InhibitionConfirmatorydepositor-specified cross reference: EGFR T790M/L858R Kinase Inhibition
1727Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay: EGFR L858R Kinase InhibitionConfirmatorydepositor-specified cross reference: EGFR L858R Kinase Inhibition
1728Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay: c-Raf InhibitionConfirmatorydepositor-specified cross reference: c-Raf Inhibition
1729Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay: EGFR T790M Kinase InhibitionConfirmatorydepositor-specified cross reference: EGFR T790M Kinase Inhibition
1730Counterscreen Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening AssayConfirmatorydepositor-specified cross reference: AlphaScreen counterscreen for primary assay
1731Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay: EGFR Kinase InhibitionConfirmatorydepositor-specified cross reference: EGFR Kinase Inhibition
1732Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay: MEK InhibitionConfirmatorydepositor-specified cross reference: MEK Inhibition
Description:
qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay

NIH Chemical Genomics Center [NCGC]
NIH Molecular Libraries Screening Centers Network [MLSCN]

MLSCN Grant: 1X01MH082406-01
Assay Submitter (PI): Dr. Wei Zheng, NCGC/NIH

NCGC Assay Overview:

The Ras/extracellular-signal-regulated kinase (ERK) mitogen activated protein (MAP) kinase signaling pathway (ERK1/2 cascade) plays is a key role in transmitting signals from the cell surface to the nucleus (Nishida and Gotoh 1993; Chang and Karin, 2001). The cascade is initiated by the small G-protein Ras, which recruits Raf from the cytosol, where activation occurs. Alternatively, this pathway can be activated by elevating intracellular cAMP.

Activation of the ERK pathway is essential in increased cell division and cell survival. Sustained and constitutive activation of the ERK pathway, however, has been linked to uncontrolled cell proliferation, increased cell survival, and tumor progression. Thus, the ERK has been as an attractive target for cancer chemotherapy in the past few years (Sebolt-Leopold and Herrera, 2004). Given its physiological and pathological importance, assessment of ERK phosphorylation has been broadly performed in both basic research and drug discovery. Most assays for the measurement of ERK phosphorylation use the antibody-based detection methods, such as western blot and ELISA. These assays require multiple reagent additions with cell wash steps and are not suitable for high-throughput screening.

The current cell-based ERK phosphorylation assay was performed using AlphaScreen platform. AlphaScreen is a two bead-based proximity-dependent chemical energy transfer luminescent assay platform. The assay reagents (ERK SureFire(TM) kit) were supplied from TGR BioSciences (Australia). In the presence of specific antibodies, phosphorylated ERK will bring "donor" and "acceptor" beads to a proximity range (<200 nm), and subsequently lead a chemical luminescent reaction upon exciting donor beads with 680 nm laser. To exclude the assay-related false positives, we used a biotinylated rabbit IgG to perform counter-screen. The biotinylated antibody mimics the phosphorylated ERK1/2 for bringing streptavidin coated beads and protein-A coated beads to a proximity range for the AlphaScreen detection.
Protocol
Please refer to other AIDs (995, 1454, 1724, 1725, 1726, 1727, 1728, 1729, 1730, 1731, 1732) for detailed assay protocols.
Comment
This summary is written for the purposes of summarizing the probe activities from the project. MLSCN probes are given a score of 100. Molecules in the prior art are given a score of 80. Other, less active molecules in the same chemical series as the probe molecules are given a score of 50. Molecules pending validation are given a score of 10. Inactive analogues from these series are given a score of 0. The present results summarize results for select compounds chosen for validation in secondary assays. ML102 (CID 2303746) was declared a probe from this project.
Categorized Comment - additional comments and annotations
From MLP Probe Report:
Probe count: 1
MLP Probe ML# for probe 1: ML102
PubChem Substance ID (SID) for probe 1: 22409543
PubChem Compound ID (CID) for probe 1: 2303746
Probe type for probe 1: Inhibitor
IC50/EC50 (nM) for probe 1: 710
Target for probe 1: EGFR (gi: 29725609)
Anti-target for probe 1: c-Raf, Mek-1
Fold selectivity for probe 1: >100
NCBI Book chapter link for probe 1: http://www.ncbi.nlm.nih.gov/books/NBK47349/ (ID: 2359332)
Grant number for probe 1: MH082406-01
NCBI Book chapter title for probe 1: HTS for Identification of Inhibitors against the ERK Signaling Pathway using a Homogenous Cell-based Assay
Result Definitions
Show more
TIDNameDescriptionHistogramTypeUnit
OutcomeThe BioAssay activity outcomeOutcome
ScoreThe BioAssay activity ranking scoreInteger
1Activity SummaryNature of interaction of the sample with the ERK-phosphorylation cascade.String
2ERK Phosphorylation IC50; Vasopressin StimulatedThe concentration of sample yielding half-maximal inhibition of ERK phosphorylation in the cell-based assay when stimulated by vasopressin.FloatμM
3ERK Phosphorylation IC50; EGF StimulatedThe concentration of sample yielding half-maximal inhibition of ERK phosphorylation in the cell-based assay when stimulated by epidermal growth factor.FloatμM
4AlphaScreen Platform Counterscreen IC50The concentration of sample yielding half-maximal inhibition AlphaScreen platform signal.FloatμM
5MEK IC50The concentration of sample yielding half-maximal inhibition of MEK in purified enzyme assay.FloatμM
6c-Raf IC50The concentration of sample yielding half-maximal inhibition of c-Raf in purified enzyme assay.FloatμM
7EGFR IC50*The concentration of sample yielding half-maximal inhibition of EGFR in purified enzyme assay.FloatμM
8EGFR L858R IC50The concentration of sample yielding half-maximal inhibition of EGFR L858R in purified enzyme assay.FloatμM
9EGFR T790M IC50The concentration of sample yielding half-maximal inhibition of EGFR T790M in purified enzyme assay.FloatμM
10EGFR T790M/L858R IC50The concentration of sample yielding half-maximal inhibition of EGFR T790M/L858R in purified enzyme assay.FloatμM

* Activity Concentration.
Additional Information
Grant Number: MH082406-01

Data Table (Concise)
Data Table ( Complete ):     View Active Data    View All Data
Classification
PageFrom: